PANDEMIC DIAGNOSTIC MARKETS BY PATHOGEN AND TECHNOLOGY TYPE AND BY REGION WITH CUSTOMIZED FORECASTING/ANALYSIS AND EXECUTIVE AND CONSULTANT GUIDES. 2020-2024
New pathogens create a new growing global industry. Wuhan virus joins the list.....
Pandemics pathogens are creating a whole new industry. The rise of new pandemic pathogens is not going away but creating global growing demand for new diagnostics that can reach the market in record time. Demand is very large and lucrative, and growing, but players need to be able to move quickly to seize an opportunity.
The latest pandemic, 2019-nCoV, out of Wuhan China is just one in a growing list of pathogen evolutions that are occurring with regularity. From SARS to MERS to Ebola the list keeps growing. And WHO says to prepare for more. Diagnostics is key with widespread demand for reliable and fast testing. This is a growing opportunity for all diagnostic companies that will become a mainstream area of operations for some. Understand the opportunity and the risk with this in depth report.
Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges
See the Table of Contents.
Send an email to us at email@example.com and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part. And we will not pester you with phone calls!
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research and a member of the American Association for Clinical Chemistry.
He is an experienced business and clinical professional with considerable experience in mergers and acquisitions . He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years . Mr. Powell’s education includes:
Finance for Senior Executives - Harvard Business School
Market Research - Burke Institute
M.B.A. (Finance and Policy) University of BC
B.Sc. (Chemistry) University of BC